RKIP: much more than Raf kinase inhibitory protein
Affiliations
Affiliations
- Faculty of Medicine, Department of Pathology, Kuwait University Health Sciences Centre, Safat, Kuwait. fahd@al-mulla.org
Abstract
From its discovery as a phosphatidylethanolamine-binding protein in bovine brain to its designation as a physiological inhibitor of Raf kinase protein, RKIP has emerged as a critical molecule for maintaining subdued, well-orchestrated cellular responses to stimuli. The disruption of RKIP in a wide range of pathologies, including cancer, Alzheimer's disease, and pancreatitis, makes it an exciting target for individualized therapy and disease-specific interventions. This review attempts to highlight recent advances in the RKIP field underscoring its potential role as a master modulator of many pivotal intracellular signaling cascades that control cellular growth, motility, apoptosis, genomic integrity, and therapeutic resistance. Specific biological and functional niches are highlighted to focus future research towards an enhanced understanding of the multiple roles of RKIP in health and disease.
Similar articles
Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor.
Granovsky AE, Rosner MR.Cell Res. 2008 Apr;18(4):452-7. doi: 10.1038/cr.2008.43.PMID: 18379591 Review.
Raf kinase inhibitor protein regulation of raf and MAPK signaling.
Hagan S, Garcia R, Dhillon A, Kolch W.Methods Enzymol. 2006;407:248-59. doi: 10.1016/S0076-6879(05)07021-7.PMID: 16757329
Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target.
Zeng L, Imamoto A, Rosner MR.Expert Opin Ther Targets. 2008 Oct;12(10):1275-87. doi: 10.1517/14728222.12.10.1275.PMID: 18781826 Review.
Granovsky AE, Clark MC, McElheny D, Heil G, Hong J, Liu X, Kim Y, Joachimiak G, Joachimiak A, Koide S, Rosner MR.Mol Cell Biol. 2009 Mar;29(5):1306-20. doi: 10.1128/MCB.01271-08. Epub 2008 Dec 22.PMID: 19103740 Free PMC article.
Ma J, Li F, Liu L, Cui D, Wu X, Jiang X, Jiang H.Liver Int. 2009 Apr;29(4):567-74. doi: 10.1111/j.1478-3231.2009.01981.x.PMID: 19323783
Cited by
Argueta CE, Figy C, Bouali S, Guo A, Yeung KC, Fenteany G.J Biol Chem. 2023 Apr;299(4):103023. doi: 10.1016/j.jbc.2023.103023. Epub 2023 Feb 15.PMID: 36805338 Free PMC article.
RKIP suppresses the influenza A virus‑induced airway inflammatory response via the ERK/MAPK pathway.
Ye JJ, Wei SL, Wei YY, Zhang DW, Sun L, Wu HM, Shen JL, Yu L, Wang Y, Fei GH.Int J Mol Med. 2023 Jan;51(1):1. doi: 10.3892/ijmm.2022.5204. Epub 2022 Nov 16.PMID: 36382638 Free PMC article.
A Negative Regulatory Role for RKIP in Breast Cancer Immune Response.
Bach VN, Ding J, Yeung M, Conrad T, Odeh HN, Cubberly P, Figy C, Ding HF, Trumbly R, Yeung KC.Cancers (Basel). 2022 Jul 24;14(15):3605. doi: 10.3390/cancers14153605.PMID: 35892864 Free PMC article.
Zhao C, Zhu M, Guo Y, Sun J, Ma W, Wang X.Plants (Basel). 2022 Jun 15;11(12):1576. doi: 10.3390/plants11121576.PMID: 35736727 Free PMC article.
Känel P, Noll GA, Schroedter K, Naffin E, Kronenberg J, Busswinkel F, Twyman RM, Klämbt C, Prüfer D.Aging (Albany NY). 2022 Apr 8;14(7):2989-3029. doi: 10.18632/aging.204005. Epub 2022 Apr 8.PMID: 35396341 Free PMC article.
References
https://pubmed.ncbi.nlm.nih.gov/